A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Moderna to pay up to $2.25B to end mRNA vaccine patent fight
Moderna to pay up to $2.25B to end mRNA vaccine patent fight
Moderna’s combination flu, COVID shot wins over European drug regulators
Moderna’s combination flu, COVID shot wins over European drug regulators
FDA reverses course on Moderna’s flu vaccine
FDA reverses course on Moderna’s flu vaccine
Moderna shares jump as company affirms growth outlook
Moderna shares jump as company affirms growth outlook
FDA refuses to review Moderna’s mRNA flu vaccine
FDA refuses to review Moderna’s mRNA flu vaccine
Moderna cancer vaccine holds up; IO Biotech considers a sale
Moderna cancer vaccine holds up; IO Biotech considers a sale
Moderna, searching for a rebound, to seek approval of mRNA flu shot
Moderna, searching for a rebound, to seek approval of mRNA flu shot
Moderna gets funding for H5 pandemic influenza vaccine
Moderna gets funding for H5 pandemic influenza vaccine
Moderna secures $1.5B lifeline as it looks to break even in 2028
At an analyst day event, Moderna said it wants to invest revenue from a hopefully expanded seasonal vaccine franchise into oncology and rare disease programs, to “set t...
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page